View in EDS

Nondisclosure of HIV Status in a Clinical Trial Setting: Antiretroviral Drug Screening Can Help Distinguish Between Newly Diagnosed and Previously Diagnosed HIV Infection.

Saved in:
Bibliographic Details
Title: Nondisclosure of HIV Status in a Clinical Trial Setting: Antiretroviral Drug Screening Can Help Distinguish Between Newly Diagnosed and Previously Diagnosed HIV Infection.
Authors: Marzinke, Mark A.1, Clarke, William1, Wang, Lei2, Cummings, Vanessa1, Liu, Ting-Yuan2, Piwowar-Manning, Estelle1, Breaud, Autumn1, Griffith, Sam3, Buchbinder, Susan4, Shoptaw, Steven5, del Rio, Carlos6, Magnus, Manya7, Mannheimer, Sharon8, Fields, Sheldon D.9, Mayer, Kenneth H.10, Wheeler, Darrell P.11, Koblin, Beryl A.12, Eshleman, Susan H.1, Fogel, Jessica M.1
Source: Clinical Infectious Diseases. Jan2014, Vol. 58 Issue 1, p117-120. 4p.
Database: Environment Complete
Description
ISSN:10584838
DOI:10.1093/cid/cit672